Shaping the way Brands Communicate

The oncology landscape has changed dramatically in recent years with an influx of new treatments including immunotherapies, CAR-T and other novel MOAs entering the market. The influx of change has meant Oncologists are confused and unable to clearly distinguish across...
Adelphi Informs NICE Guidance

Adelphi Informs NICE Guidance

NICE has used Adelphi’s research project as a pilot to inform guidance to set standards around patient preference study design. Adelphi’s client wanted a patient preference study that would stand up to NICE scrutiny for their HTA submission. Together with our client,...